Bio-Works Technologies Past Earnings Performance
Past criteria checks 0/6
Bio-Works Technologies's earnings have been declining at an average annual rate of -2%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been growing at an average rate of 38.9% per year.
Key information
-2.0%
Earnings growth rate
11.7%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 38.9% |
| Return on equity | -129.0% |
| Net Margin | -129.4% |
| Next Earnings Update | 23 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bio-Works Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 44 | -57 | 82 | 0 |
| 30 Sep 23 | 45 | -54 | 81 | 0 |
| 30 Jun 23 | 45 | -50 | 81 | 0 |
| 31 Mar 23 | 43 | -48 | 78 | 0 |
| 31 Dec 22 | 41 | -45 | 75 | 0 |
| 30 Sep 22 | 38 | -45 | 72 | 0 |
| 30 Jun 22 | 34 | -45 | 70 | 0 |
| 31 Mar 22 | 45 | -29 | 66 | 0 |
| 31 Dec 21 | 56 | -13 | 63 | 0 |
| 30 Sep 21 | 50 | -14 | 58 | 0 |
| 30 Jun 21 | 44 | -15 | 54 | 0 |
| 31 Mar 21 | 25 | -29 | 51 | 0 |
| 31 Dec 20 | 7 | -45 | 49 | 0 |
| 30 Sep 20 | 7 | -42 | 49 | 0 |
| 30 Jun 20 | 7 | -42 | 49 | 0 |
| 31 Mar 20 | 7 | -45 | 51 | 0 |
| 31 Dec 19 | 6 | -42 | 46 | 0 |
| 30 Sep 19 | 6 | -55 | 53 | 0 |
| 30 Jun 19 | 5 | -51 | 49 | 0 |
| 31 Mar 19 | 5 | -41 | 39 | 0 |
| 31 Dec 18 | 7 | -38 | 37 | 0 |
| 30 Sep 18 | 6 | -25 | 27 | 0 |
| 30 Jun 18 | 6 | -22 | 26 | 0 |
| 31 Mar 18 | 7 | -26 | 30 | 0 |
| 31 Dec 17 | 6 | -24 | 29 | 0 |
| 30 Sep 17 | 6 | -20 | 25 | 0 |
| 31 Dec 16 | 6 | -17 | 24 | 0 |
| 31 Dec 15 | 3 | -12 | 17 | 0 |
Quality Earnings: 1BD is currently unprofitable.
Growing Profit Margin: 1BD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1BD is unprofitable, and losses have increased over the past 5 years at a rate of 2% per year.
Accelerating Growth: Unable to compare 1BD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1BD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).
Return on Equity
High ROE: 1BD has a negative Return on Equity (-129.04%), as it is currently unprofitable.